患者管理ソリューション市場：コンポーネント別（ハードウェア、サービス、ソフトウェア）、展開形態別（オンクラウド、オンプレミス）、エンドユーザー別、用途別-2023年～2030年の世界予測

患者管理ソリューションの世界市場は、2023年に164億2,000万米ドル、CAGR13.71%で大きく成長し、2030年には404億2,000万米ドルという驚異的な規模に達すると予測されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界の患者管理ソリューション市場を評価するために不可欠です。事業戦略と製品満足度の主要指標を調査することで、ベンダーの包括的な評価を提供し、ユーザーは特定のニーズに基づいた情報をもとに意思決定を行うことができます。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客ベース、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展：有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化：新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向：COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション：将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします：

1.患者管理ソリューションの世界市場規模および予測は？

2.予測期間中、世界の患者管理ソリューション市場を形成するCOVID-19の阻害要因と影響は？

3.患者管理ソリューションの世界市場において予測期間中に投資すべき製品/セグメント/アプリケーション/分野は？

4.患者管理ソリューションの世界市場における競争戦略は？

5.患者管理ソリューションの世界市場における技術動向と規制の枠組みは？

6.患者管理ソリューションの世界市場における主要ベンダーの市場シェアは？

7.患者管理ソリューションの世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • モバイルヘルスケアアプリの採用の増加
    • 患者中心のケアを推進する政府の取り組み
    • ヘルスケア情報技術への投資
  • 抑制要因
    • 患者のデータセキュリティの脅威
  • 機会
    • ウェアラブル健康技術の開発が進む
    • 患者情報の管理と識別における継続的な開発
    • ヘルスケアにおけるクラウドベースのモデルの受け入れの高まり
  • 課題
    • ソリューション導入コストが高い
• 市場動向
• COVID-19の累積的な影響
• ロシア・ウクライナ紛争の累積的影響
• 高インフレの累積的影響
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 規制の枠組み
• 顧客のカスタマイズ
  • 技術動向
  • 規制の枠組み

第6章 患者管理ソリューション市場：コンポーネント別

• ハードウェア
• サービス
• ソフトウェア

第7章 患者管理ソリューション市場：展開モード別

• オンクラウド
• オンプレミス

第8章 患者管理ソリューション市場：エンドユーザー別

• ヘルスケア支払者
• 病院と医療提供者
• 製薬会社

第9章 患者管理ソリューション市場：用途別

• 財務健全性管理
• 健康管理
• 家庭の健康管理
• 社会的および行動的管理

第10章 南北アメリカの患者管理ソリューション市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域の患者管理ソリューション市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの患者管理ソリューション市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• FPNVポジショニングマトリクス
• 市場シェア分析：主要企業別
• 競合シナリオ分析：主要企業別

第14章 掲載企業一覧

第15章 付録

• ディスカッションガイド
• ライセンスと価格について

LIST OF FIGURES

• FIGURE 1. PATIENT ENGAGEMENT SOLUTION MARKET RESEARCH PROCESS
• FIGURE 2. PATIENT ENGAGEMENT SOLUTION MARKET SIZE, 2022 VS 2030
• FIGURE 3. PATIENT ENGAGEMENT SOLUTION MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2022 VS 2030 (%)
• FIGURE 5. PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2022 VS 2030 (%)
• FIGURE 6. PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
• FIGURE 7. PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
• FIGURE 8. PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 9. PATIENT ENGAGEMENT SOLUTION MARKET DYNAMICS
• FIGURE 10. PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 11. PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 12. PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 13. PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 15. UNITED STATES PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 18. PATIENT ENGAGEMENT SOLUTION MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 19. PATIENT ENGAGEMENT SOLUTION MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. PATIENT ENGAGEMENT SOLUTION MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. PATIENT ENGAGEMENT SOLUTION MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 5. PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY HARDWARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 6. PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 8. PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
• TABLE 9. PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY ON- CLOUD, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY ON-PREMISE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 12. PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY HEALTHCARE PAYERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY HOSPITALS & PROVIDERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 16. PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY FINANCIAL HEALTH MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY HEALTH MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY HOME HEALTH MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SOCIAL & BEHAVIOURAL MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 25. ARGENTINA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 26. ARGENTINA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
• TABLE 27. ARGENTINA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 28. ARGENTINA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 29. BRAZIL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 30. BRAZIL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
• TABLE 31. BRAZIL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 32. BRAZIL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 33. CANADA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 34. CANADA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
• TABLE 35. CANADA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 36. CANADA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 37. MEXICO PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 38. MEXICO PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
• TABLE 39. MEXICO PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 40. MEXICO PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 41. UNITED STATES PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 42. UNITED STATES PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 43. UNITED STATES PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
• TABLE 44. UNITED STATES PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 45. UNITED STATES PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 46. ASIA-PACIFIC PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 47. ASIA-PACIFIC PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 48. ASIA-PACIFIC PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
• TABLE 49. ASIA-PACIFIC PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 50. ASIA-PACIFIC PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 51. AUSTRALIA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 52. AUSTRALIA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
• TABLE 53. AUSTRALIA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 54. AUSTRALIA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 55. CHINA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 56. CHINA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
• TABLE 57. CHINA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 58. CHINA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 59. INDIA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 60. INDIA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
• TABLE 61. INDIA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 62. INDIA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 63. INDONESIA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 64. INDONESIA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
• TABLE 65. INDONESIA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 66. INDONESIA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 67. JAPAN PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 68. JAPAN PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
• TABLE 69. JAPAN PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 70. JAPAN PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 71. MALAYSIA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 72. MALAYSIA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
• TABLE 73. MALAYSIA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 74. MALAYSIA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 75. PHILIPPINES PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 76. PHILIPPINES PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
• TABLE 77. PHILIPPINES PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 78. PHILIPPINES PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 79. SINGAPORE PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 80. SINGAPORE PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
• TABLE 81. SINGAPORE PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 82. SINGAPORE PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 83. SOUTH KOREA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 84. SOUTH KOREA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
• TABLE 85. SOUTH KOREA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 86. SOUTH KOREA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 87. TAIWAN PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 88. TAIWAN PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
• TABLE 89. TAIWAN PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 90. TAIWAN PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 91. THAILAND PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 92. THAILAND PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
• TABLE 93. THAILAND PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 94. THAILAND PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 95. VIETNAM PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 96. VIETNAM PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
• TABLE 97. VIETNAM PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 98. VIETNAM PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 99. EUROPE, MIDDLE EAST & AFRICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 100. EUROPE, MIDDLE EAST & AFRICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 101. EUROPE, MIDDLE EAST & AFRICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
• TABLE 102. EUROPE, MIDDLE EAST & AFRICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 103. EUROPE, MIDDLE EAST & AFRICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 104. DENMARK PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 105. DENMARK PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
• TABLE 106. DENMARK PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 107. DENMARK PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 108. EGYPT PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 109. EGYPT PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
• TABLE 110. EGYPT PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 111. EGYPT PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 112. FINLAND PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 113. FINLAND PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
• TABLE 114. FINLAND PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 115. FINLAND PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 116. FRANCE PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 117. FRANCE PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
• TABLE 118. FRANCE PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 119. FRANCE PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 120. GERMANY PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 121. GERMANY PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
• TABLE 122. GERMANY PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 123. GERMANY PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 124. ISRAEL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 125. ISRAEL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
• TABLE 126. ISRAEL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 127. ISRAEL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 128. ITALY PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 129. ITALY PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
• TABLE 130. ITALY PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 131. ITALY PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 132. NETHERLANDS PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 133. NETHERLANDS PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
• TABLE 134. NETHERLANDS PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 135. NETHERLANDS PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 136. NIGERIA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 137. NIGERIA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
• TABLE 138. NIGERIA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 139. NIGERIA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 140. NORWAY PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 141. NORWAY PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
• TABLE 142. NORWAY PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 143. NORWAY PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 144. POLAND PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 145. POLAND PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
• TABLE 146. POLAND PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 147. POLAND PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 148. QATAR PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 149. QATAR PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
• TABLE 150. QATAR PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 151. QATAR PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 152. RUSSIA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 153. RUSSIA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
• TABLE 154. RUSSIA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 155. RUSSIA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 156. SAUDI ARABIA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 157. SAUDI ARABIA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
• TABLE 158. SAUDI ARABIA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 159. SAUDI ARABIA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 160. SOUTH AFRICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 161. SOUTH AFRICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
• TABLE 162. SOUTH AFRICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 163. SOUTH AFRICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 164. SPAIN PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 165. SPAIN PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
• TABLE 166. SPAIN PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 167. SPAIN PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 168. SWEDEN PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 169. SWEDEN PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
• TABLE 170. SWEDEN PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 171. SWEDEN PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 172. SWITZERLAND PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 173. SWITZERLAND PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
• TABLE 174. SWITZERLAND PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 175. SWITZERLAND PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 176. TURKEY PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 177. TURKEY PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
• TABLE 178. TURKEY PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 179. TURKEY PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 180. UNITED ARAB EMIRATES PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 181. UNITED ARAB EMIRATES PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
• TABLE 182. UNITED ARAB EMIRATES PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 183. UNITED ARAB EMIRATES PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 184. UNITED KINGDOM PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 185. UNITED KINGDOM PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
• TABLE 186. UNITED KINGDOM PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 187. UNITED KINGDOM PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 188. PATIENT ENGAGEMENT SOLUTION MARKET, FPNV POSITIONING MATRIX, 2022
• TABLE 189. PATIENT ENGAGEMENT SOLUTION MARKET SHARE, BY KEY PLAYER, 2022
• TABLE 190. PATIENT ENGAGEMENT SOLUTION MARKET LICENSE & PRICING

The Global Patient Engagement Solution Market is forecasted to grow significantly, with a projected USD 16.42 billion in 2023 at a CAGR of 13.71% and expected to reach a staggering USD 40.42 billion by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Patient Engagement Solution Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Patient Engagement Solution Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Component, market is studied across Hardware, Services, and Software. The Software is projected to witness significant market share during forecast period.

Based on Deployment Mode, market is studied across On- Cloud and On-Premise. The On- Cloud is projected to witness significant market share during forecast period.

Based on End-User, market is studied across Healthcare Payers, Hospitals & Providers, and Pharmaceutical Companies. The Healthcare Payers is projected to witness significant market share during forecast period.

Based on Application, market is studied across Financial Health Management, Health Management, Home Health Management, and Social & Behavioural Management. The Home Health Management is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Patient Engagement Solution Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Patient Engagement Solution Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Patient Engagement Solution Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Patient Engagement Solution Market?

4. What is the competitive strategic window for opportunities in the Global Patient Engagement Solution Market?

5. What are the technology trends and regulatory frameworks in the Global Patient Engagement Solution Market?

6. What is the market share of the leading vendors in the Global Patient Engagement Solution Market?

7. What modes and strategic moves are considered suitable for entering the Global Patient Engagement Solution Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Patient Engagement Solution Market, by Component, 2022 vs 2030
• 4.3. Patient Engagement Solution Market, by Deployment Mode, 2022 vs 2030
• 4.4. Patient Engagement Solution Market, by End-User, 2022 vs 2030
• 4.5. Patient Engagement Solution Market, by Application, 2022 vs 2030
• 4.6. Patient Engagement Solution Market, by Region, 2022 vs 2030

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising adoption of mobile health apps
    • 5.1.1.2. Government initiatives to promote the patient-centered care
    • 5.1.1.3. Investments in the healthcare information technology
  • 5.1.2. Restraints
    • 5.1.2.1. Patient's data security threats
  • 5.1.3. Opportunities
    • 5.1.3.1. Growing development of wearable health technology
    • 5.1.3.2. On-going developments in patient information management and identification
    • 5.1.3.3. Rising acceptance of cloud-based models in healthcare
  • 5.1.4. Challenges
    • 5.1.4.1. High solution deployment cost
• 5.2. Market Trends
• 5.3. Cumulative Impact of COVID-19
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework
• 5.9. Client Customization
  • 5.9.1. Technology Trend
  • 5.9.2. Regulatroy Framework

6. Patient Engagement Solution Market, by Component

• 6.1. Introduction
• 6.2. Hardware
• 6.3. Services
• 6.4. Software

7. Patient Engagement Solution Market, by Deployment Mode

• 7.1. Introduction
• 7.2. On- Cloud
• 7.3. On-Premise

8. Patient Engagement Solution Market, by End-User

• 8.1. Introduction
• 8.2. Healthcare Payers
• 8.3. Hospitals & Providers
• 8.4. Pharmaceutical Companies

9. Patient Engagement Solution Market, by Application

• 9.1. Introduction
• 9.2. Financial Health Management
• 9.3. Health Management
• 9.4. Home Health Management
• 9.5. Social & Behavioural Management

10. Americas Patient Engagement Solution Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Patient Engagement Solution Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Patient Engagement Solution Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. FPNV Positioning Matrix
• 13.2. Market Share Analysis, By Key Player
• 13.3. Competitive Scenario Analysis, By Key Player

14. List of Company Mentioned

15. Appendix

• 15.1. Discussion Guide
• 15.2. License & Pricing